Cargando…
Harnessing Macrophages for Controlled-Release Drug Delivery: Lessons From Microbes
With the effectiveness of therapeutic agents ever decreasing and the increased incidence of multi-drug resistant pathogens, there is a clear need for administration of more potent, potentially more toxic, drugs. Alternatively, biopharmaceuticals may hold potential but require specialized protection...
Autores principales: | Visser, Johan Georg, Van Staden, Anton Du Preez, Smith, Carine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355695/ https://www.ncbi.nlm.nih.gov/pubmed/30740053 http://dx.doi.org/10.3389/fphar.2019.00022 |
Ejemplares similares
-
Harnessing Microglia and Macrophages for the Treatment of Glioblastoma
por: Prionisti, Ioanna, et al.
Publicado: (2019) -
Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery
por: La-Beck, Ninh M., et al.
Publicado: (2019) -
Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery
por: Sunildutt, Naina, et al.
Publicado: (2023) -
Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines
por: Han, Lu, et al.
Publicado: (2021) -
Macrophage–Microbe Interactions: Lessons from the Zebrafish Model
por: Yoshida, Nagisa, et al.
Publicado: (2017)